Audit Committee Charter

 

Committee Members

Thomas G. Auchincloss, Jr.
 
 
Thomas G. Auchincloss, Jr.
Managing Partner, Counterpoint Trading Company, LLC

Thomas G. Auchincloss, Jr. has served as a member of our board of directors since December 2014.  Since October 2013, Mr. Auchincloss has served as Managing Partner at Counterpoint Trading Company, LLC, a private investment firm.  From May 2005 to August 2007, Mr. Auchincloss worked as Chief Financial Officer of Metabolix, Inc., a public biomaterials company.  Prior to joining Metabolix, Mr. Auchincloss served as a consultant with Metabolix from April 2002 to May 2005 providing business development, financial and strategic consulting services.  From 1994 to 2001, Mr. Auchincloss served in a variety of positions at Vertex Pharmaceuticals Incorporated, most recently as vice president, finance and treasurer. Mr. Auchincloss is trustee and Treasurer of Kieve Wavus Education, Inc. a not-for-profit camp and education organization. Mr. Auchincloss received a B.S. in Business Administration from Babson College and an M.B.A. in Finance from the Wharton School. We believe that Mr. Auchincloss’ financial and industry experience, including his experience as the chief financial officer of a publically traded biomaterials company, makes him a key contributor to our board of directors.

Wilfred E. Jaeger, M.D.
 
 
Wilfred E. Jaeger, M.D.
Partner, Three Arch Partners

Wilfred E. Jaeger, M.D. has served as a member of our board of directors since May 2006. Dr. Jaeger co-founded Three Arch Partners, a venture capital firm, in 1993 and has served as a Partner since that time. Prior to co-founding Three Arch Partners, Dr. Jaeger was a general partner at Schroder Ventures. He is also a member of the board of directors of Threshold Pharmaceuticals, Inc., a public pharmaceutical company, as well as numerous private companies. Dr. Jaeger received a B.S. in Biology from the University of British Columbia, his M.D. from the University of British Columbia School of Medicine and an M.B.A. from Stanford University. In addition to representing one of our principal stockholders, we believe that that Dr. Jaeger’s financial and medical knowledge and experience allows him to be a key contributor to our board of directors.

Christine van Heek
 
 
Christine van Heek
Former Corporate Officer and President, Therapeutics Division, Genzyme Corporation

Ms. van Heek has served as a member of our Board of Directors since April 2016. Ms. van Heek has served as an advisor and consultant to several companies in the bio-pharmaceutical industry.   From 1991 to 2003, Ms. van Heek served in various roles at Genzyme Corporation, a biotechnology company, including positions as Corporate Officer and President, Therapeutics Division; General Manager, Renal Division; and Vice President, Global Marketing.  In addition, she has held various sales and marketing positions at Genentech, Inc. and Caremark/HHCA. From 2007-2014, Ms. van Heek served as a member of the board of directors of Affymax, Inc., a biopharmaceutical company.  Ms. van Heek currently serves on the Board of Directors for Visioneering Technologies, Inc. She holds a B.S.N. from the University of Iowa and received her M.B.A. from Lindenwood University in St. Louis. We believe that Ms. van Heek's industry experience, including her extensive experience in strategic roles of a publicly traded biomaterials company, make her a key contributor to our Board of Directors.